[Comment] Two steps forward for myelin repair in multiple sclerosis

Multiple sclerosis is a convolution of inflammation, degeneration, and variable repair, the timing and extent of which determines whether the clinical course is slow with periods of recovery or a progressive worsening of symptoms. Accordingly, to improve outcomes for patients with multiple sclerosis —particularly progressive multiple sclerosis—multipronged, combination therapies are probably needed. Existing therapies that modulate the immune system, such as alemtuzumab, are increasingly effective.
Source: Lancet Neurology - Category: Neurology Authors: Tags: Comment Source Type: research